Presenilin mutations disrupt selenium uptake and thus inhibit GPX4 expression, increasing the sensitivity of multiple cell types to ferroptosis.560 Presenilin mutations in patients with AD may contribute to neurodegeneration by downregulating GPX4 and promoting ferroptosis. The gene discussed is GPX4; the disease is Alzheimer disease.